Accelerate Your Preclinical Research By Innovative Methods.

Customizing in-vitro and in-vivo services for your success.

Recently At InnoSer

InnoSer and OrganoTherapeutics to Offer Midbrain Organoids

InnoSer is joining forces with OrganoTherapeutics to make midbrain organoids available for screening and development of pharmaceutical compounds. This partnership will enable providing midbrain organoids commercially as a platform for Parkinson’s disease research. CEO...

InnoSer and TheraIndx Strategic Partnership

InnoSer and TheraIndx announce their strategic partnership to better serve pharmaceutical and biomedical companies worldwide. Jan Bartels, the CEO of InnoSer, states: “Both companies offer unique service portfolios and bring a lot of aligned added value to our global...

InnoSer gets new cell culture facilities

InnoSer is expanding its infrastructure to better its in vitro services. These specialized services include syngeneic oncology models, PBMC and immune population work in vitro/ex vivo, organoid culture, PDX passage work and any in vitro compound screening on fresh...
THERAPEUTIC AREAS

We Specialize In

Kidney Disease (PKD)

Learn More

Parkinson’s Disease

Learn More

Oncology

Learn More

Alzheimer’s Disease

Learn More

OUR INNOVATIVE METHODS

Combining In-Vivo And In-Vitro

By our state-of-the-art methods from organoids to genetically engineered mice, we provide reliability and transferability in your results.

Low success rates of drugs that are able to go from bench to the clinic continue to disappoint not only researchers and pharmaceutical companies but also patients and their families. The resulting expenses affect the costs of all drugs that reach the market.

This calls for more stringent criteria at the preclinical phase, ensuring only the drugs that are effective and safe for humans continue to the clinical phases. InnoSer excels in combining in vitro and in vivo disease modelling to offer the most reliable screening platforms.

By developing in-vitro technologies and knowledge that offer higher predictive capacity, we support the transition to a world that relies less on animal testing.

GET IN TOUCH WITH US

Tell Us About Your Work

We always keep close contact with our customers to identify and understand their needs better. All our services can be customized for your project requirements.

OUR CLIENTS ABOUT US

Academic And Commercial Expertise

“We have worked with InnoSer in several projects and what truly distinguished them was flexibility, keeping tight time lines and a deep scientific knowledge in GEMM generation. The latter was proven in a large project with several leading Dutch universities called project IMPAct, which was successfully finalized in November 2014.”

 

Prof. Dr. Marten Smidt, Swammerdam Institute of Life Sciences, University of Amsterdam

“Since two years I am working with InnoSer and my research group is extremely happy with their service levels, GEMM support and pro-active communication. By working with InnoSer we were able to reduce cost by highly efficient colony management and making use of their cryopreservation program.”

 

Prof. Dr. Leon de Windt, Maastricht University

Phone

+32 (0)11 14 07 68

Headquarters

InnoSer België NV

Agoralaan A bis
3590 Diepenbeek
Belgium

 

Email

info@innoserlaboratories.com

Subsidiary

InnoSer Nederland BV

Zernikedreef 9
2333 CK Leiden
The Netherlands